Exozymes Inc.: director Rayo Edgardo Javier received 25,000 shares

What happened The filing reports that Rayo Edgardo Javier, a director of Exozymes Inc., received a grant (A) of 25,000 shares on Oct 1, 2026. The filing shows a price of $0.00 and a total value of $0 (derivative).

Key details

• Transaction date and price: Oct 1, 2026 — Award (A) of 25,000 shares at $0.00 (derivative).
• Shares owned after the transaction: not reported in the filing.
• Footnote: the option vests in 12 quarterly installments (11 installments of 2,083 shares and a final installment of 2,087 shares), beginning Dec 31, 2026 and ending Sep 30, 2029, subject to continued service; option expires Oct 1, 2033.
• Filing date and timeliness: the Form 4 was filed on Oct 19, 2026, after the Oct 1, 2026 transaction.

Why it may matter

• This was a derivative award (an option grant) with a multi-year vesting schedule; no exercise or market sale is reported in this filing. This filing does not show why the insider traded or why the company acted.